CAD4COVID is helping more and more clinicians in the treatment of suspected COVID-19 patients. Since its launch in April of this year, CAD4COVID-CT has analysed more than 2700 scans in 19 countries worldwide. All free of charge. Now, the FDA has permitted the software to be used in the US and we can help even more people with the diagnosis of CAD4COVID.